Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2022-04-21 Board/Management Inform…
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
Board/Management Information Classification · 100% confidence The document is an announcement from Guangdong Tannery Limited regarding the resignation of the company secretary and authorised representative, and the appointment of a new company secretary and authorised representative. It includes biographical details of the new appointee and expresses gratitude to the outgoing secretary. There is no financial data, no discussion of financial results, no mention of shareholder votes, no legal proceedings, no capital changes, and no report publication. The content clearly relates to changes in senior management positions, specifically the company secretary and authorised representative roles. According to the filing definitions, this fits the category of Board/Management Information (MANG). The document length is short and it is an announcement, not a report or presentation.
2022-04-21 English
Date of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a short announcement from Guangdong Tannery Limited stating the date of a board meeting to consider and approve the unaudited financial information for the quarter ended 31 March 2022. It does not contain any actual financial data or detailed report content but merely announces the upcoming board meeting and the intended approval of quarterly financial information. The document length is only 1365 characters, which is very short and fits the pattern of an announcement rather than a full report. According to the rules, such announcements about upcoming board meetings and report approvals are classified as Regulatory Filings (RNS) because they do not contain substantive financial data or the report itself.
2022-04-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 March 2022. It details movements in issued shares, share options, warrants, convertibles, and other agreements related to share issuance. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share movements. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to share capital movements and compliance with listing rules. The document length is 3746 characters, which is relatively short and focused on regulatory compliance information rather than a full report. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories like Share Issue/Capital Change (SHA) because it reports no changes in issued shares (increase/decrease is zero) and no new share issues or repurchases are reported.
2022-04-01 English
2021 Annual Results Announcement
Annual Report Classification · 95% confidence The document is titled '2021 Annual Results Announcement' and contains detailed consolidated financial statements including profit or loss, comprehensive income, and financial position for the year ended 31 December 2021. It includes notes on basis of preparation, accounting policies, segment information, and revenue analysis. The length is about 15,000 characters, indicating a full report rather than a brief announcement. The content is consistent with a comprehensive annual financial report covering the full fiscal year, which matches the definition of an Annual Report (10-K). There is no indication that this is merely an announcement of a report or a certification, so it is not RPA or RNS. Therefore, the document should be classified as an Annual Report (10-K). FY 2021
2022-03-25 English
Date of Board Meeting
Report Publication Announcement Classification · 95% confidence The document is a short announcement from Guangdong Tannery Limited stating the date of a board meeting to consider and approve the audited annual results for the year ended 31 December 2021. It does not contain the actual financial results or detailed report, but merely announces the upcoming board meeting where the results will be approved. The document length is only 1355 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the rules, such announcements about the timing of report approval or publication are classified as Report Publication Announcements (RPA).
2022-03-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
Regulatory Filings Classification · 95% confidence The document is a monthly return report for an equity issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules. It details movements in securities, issued shares, and confirms no changes in share capital or other share-related activities for the month ended 28 February 2022. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share movements. It is not an annual or interim financial report, nor an earnings release or management discussion. It is a regulatory filing related to share capital and securities movements, fitting the category of Regulatory Filings (RNS). The document length is under 5,000 characters and is a formal regulatory submission, not a report publication announcement or certification. Therefore, the best classification is Regulatory Filings (RNS).
2022-03-01 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.